{
    "code": "02024093",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024093",
    "time": "2023-08-17 21:23:07",
    "許可證字號": "衛署藥輸字第024093號",
    "註銷狀態": "已註銷",
    "註銷日期": "112\/07\/03",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "113\/10\/27",
    "發證\/登錄日期": "93\/10\/27",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202409306",
    "中文品名": "瑞塔滋膠囊200毫克",
    "英文品名": "REYATAZ CAPSULES 200MG",
    "適應症": "與其他抗反轉錄病毒劑併用，適用於治療第一型人類免疫缺乏病毒感染。",
    "劑型": "130膠囊劑",
    "包裝": "4-1000顆塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ATAZANAVIR SULFATE",
    "限制項目": "02輸　入 53依本署七七公告事項八得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "台灣必治妥施貴寶股份有限公司",
    "申請商地址": "台北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "製造廠名稱": "AstraZeneca Pharmaceuticals LP",
            "製造廠廠址": "4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620,USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "SK BIOTEK IRELAND LIMITED",
            "製造廠廠址": "WATERY LANE, SWORDS, CO. DUBLIN,K67 AY91,IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "AndersonBrecon Inc",
            "製造廠廠址": "4545 ASSEMBLY DRIVE, ROCKFORD, IL 61109 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818002610",
            "成分名稱": "ATAZANAVIR SULFATE",
            "含量描述": "",
            "含量": "227.7900000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "藍色不透明0號硬膠囊",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "膠囊蓋BMS200mg印字",
        "標記二": "膠囊體3631 印字"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02024093.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024093&Seq=438&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Reyataz USPI Mar 2018 +PCI Chinese-109-06-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024093&Seq=024&Type=9"
        },
        {
            "title": "Reyataz_Label 200mg-109-06-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024093&Seq=009&Type=8"
        },
        {
            "title": "Reyataz_Carton 200mg-109-06-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024093&Seq=008&Type=8"
        }
    ]
}